Bristol-Myers Squibb Tumbles After Cancer Treatment Flops In Key TestInvestors Business Daily • 03/09/20
Bristol-Myers shares slide 4% premarket on news of failed trial of multiple myeloma treatmentMarket Watch • 03/09/20
Why Is Bristol-Myers (BMY) Down 10.1% Since Last Earnings Report?Zacks Investment Research • 03/07/20
Bristol-Myers Squibb (BMY) Stock Moves -1.59%: What You Should KnowZacks Investment Research • 03/05/20
Bristol-Myers Squibb: Market Uncertainty Makes For A (Potential) Buying OpportunitySeeking Alpha • 02/29/20
Bristol-Myers Squibb (BMY) Stock Moves -0.87%: What You Should KnowZacks Investment Research • 02/28/20
Bristol-Myers' Liso-Cel Given Priority Review, Ability To Change Scope Of TreatmentSeeking Alpha • 02/26/20
Bristol-Myers Squibb Makes Case For Success Of Opdivo With Latest Long-Term Kidney Cancer DataSeeking Alpha • 02/21/20
7 High-Yield Stocks I'm Buying For My Retirement Portfolio In This Red-Hot MarketSeeking Alpha • 02/18/20